Gen Lin

机构：Capital Medical University, Beijing Chest Hospital · ORCID：0000-0001-9411-5519

发表论文 146 篇 · 总被引 1600 次 · h-index 20

代表论文

• ENGOT-en11/GOG-3053/KEYNOTE-B21: a randomised, double-blind, phase III study of pembrolizumab or placebo plus adjuvant chemotherapy with or without radiotherapy in patients with newly diagnosed, high-risk endometrial cancer (2024 · Annals of Oncology · 被引 88)
• Deep learning using histological images for gene mutation prediction in lung cancer: a multicentre retrospective study (2024 · The Lancet Oncology · 被引 61)
• Vebreltinib for Advanced Non–Small Cell Lung Cancer Harboring c-Met Exon 14 Skipping Mutation: A Multicenter, Single-Arm, Phase II KUNPENG Study (2024 · Journal of Clinical Oncology · 被引 34)
• First-Line Camrelizumab Versus Placebo Plus Chemotherapy With or Without Radiotherapy for Brain Metastases in NSCLC: The CTONG 2003 Randomized Placebo-Controlled Trial (2025 · Journal of Thoracic Oncology · 被引 18)
• Chinese Expert Consensus on Leptomeningeal Metastases of Lung Cancer (2025 · Thoracic Cancer · 被引 5)
• Plasma EGFR mutation ctDNA dynamics in patients with advanced EGFR-mutated NSCLC treated with Icotinib: phase 2 multicenter trial result (2024 · Scientific Reports · 被引 5)